# Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants

> **NCT00702507** · PHASE4 · COMPLETED · sponsor: **Stiefel, a GSK Company** · enrollment: 200 (actual)

## Conditions studied

- Diaper Rash

## Interventions

- **DRUG:** 0.25 % Miconazole Nitrate Ointment

## Key facts

- **NCT ID:** NCT00702507
- **Lead sponsor:** Stiefel, a GSK Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2012-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00702507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00702507, "Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00702507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*